Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blockade of NMT1 enzymatic activity inhibits N-myristoylation of VILIP3 protein and suppresses liver cancer progression
Xiangpeng Tan, Yan He, Jing Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Protein lipidation in health and disease: molecular basis, physiological function and pathological implication
Yuan Yuan, Peiyuan Li, Jianghui Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 24
Proteomic Characterization of Liver Cancer Cells Treated with Clinical Targeted Drugs for Hepatocellular Carcinoma
Hui Long, Jiafu Zhou, Caicun Zhou, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 152-152
Open Access | Times Cited: 1
The role of organoids in cancer research
Zhen Fang, Peijuan Li, Fengying Du, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Series of Desloratadine Platinum(IV) Hybrids Displaying Potent Antimetastatic Competence by Inhibiting Epithelial–Mesenchymal Transition and Arousing Immune Response
Ming Zhang, Yan Chen, Zhifang Liu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 2031-2048
Closed Access | Times Cited: 13
Proteomics: An In‐Depth Review on Recent Technical Advances and Their Applications in Biomedicine
Jing Liang, Jun Tian, Huadong Zhang, et al.
Medicinal Research Reviews (2025)
Closed Access | Times Cited: 1
Target Discovery Driven by Chemical Biology and Computational Biology
B J Lyu, Wenfeng Gou, Feifei Xu, et al.
The Chemical Record (2025)
Closed Access | Times Cited: 1
Current trends and future prospects of drug repositioning in gastrointestinal oncology
Nayeralsadat Fatemi, Mina Karimpour, Hoda Bahrami, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 5
Patient-derived xenograft models: Current status, challenges, and innovations in cancer research
Min Liu, Xiaoping Yang
Genes & Diseases (2025), pp. 101520-101520
Open Access
Aging‐induced Alternation in the Gut Microbiota Impairs Host Antibacterial Defense
Peng Gu, Rongjuan Wei, Ruofan Liu, et al.
Advanced Science (2025)
Open Access
Protein N-terminal modifications: molecular machineries and biological implications
Hanne Øye, Malin Lundekvam, Alessia Caiella, et al.
Trends in Biochemical Sciences (2025)
Open Access
Ldha Accelerates Primary Cisplatin Resistance in Lung Adenocarcinoma by Modulating Ambra1 Ubiquitination Via Moonlighting Functions
Fengguo Xu, Qiang Wang, Ying Zhang, et al.
(2025)
Closed Access
The latest progress of personalized drug screening and therapy research for common clinical tumors through the PDX model platform
Yuliang Yuan, Hongling Gao, Yanhong Li, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101225-101225
Open Access
Application of patient derived xenograft model in personalized drug screening for chondrosarcoma of head and neck: A preclinical study
Yufei Hua, Zhiyong Guo, Ying Wang, et al.
Oral Oncology (2025) Vol. 162, pp. 107222-107222
Closed Access
Molecular mechanism of ZER1-mediated recognition of N-terminal glycine in protein degradation
Chengeng Liu, Shun Zhang, Xiafei Hao, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-13
Closed Access
Multiomics analysis identifies oxidative phosphorylation as a cancer vulnerability arising from myristoylation inhibition
Erwan Beauchamp, Jay M. Gamma, Christopher R. Cromwell, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Lefamulin Overcomes Acquired Drug Resistance via Regulating Mitochondrial Homeostasis by Targeting ILF3 in Hepatocellular Carcinoma
Ying Zheng, Shengtao Ye, Shiyu Huang, et al.
Advanced Science (2024) Vol. 11, Iss. 30
Open Access | Times Cited: 3
Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer
Chengke Xie, Cheng‐Yu Liao, Hong-Yi Lin, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Human patient derived organoids: an emerging precision medicine model for gastrointestinal cancer research
Sicheng Yan, Yuxuan He, Yuehong Zhu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2
Post-translational modifications in the Protein Data Bank
Lucy C. Schofield, Jordan S. Dialpuri, Garib N. Murshudov, et al.
Acta Crystallographica Section D Structural Biology (2024) Vol. 80, Iss. 9, pp. 647-660
Open Access | Times Cited: 2
ZNF740 facilitates the malignant progression of hepatocellular carcinoma via the METTL3/HIF‑1A signaling axis
Hao Zhang, Bing Han, She Tian, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 5
Closed Access | Times Cited: 2
A Novel Oncogenic Role of Disulfidptosis-related Gene SLC7A11 in Anti-tumor Immunotherapy Response to Human Cancers
Borui Xu, Jiahua Liang, Liangmin Fu, et al.
Current Cancer Drug Targets (2024) Vol. 24, Iss. 8, pp. 846-866
Closed Access | Times Cited: 1
The Combination Sorafenib-raloxifene-loratadine as a Novel Potential Therapeutic Approach Against Human Liver Cancer
Fernanda Villarruel-Melquiades, Elizabeth Hernandez-Gallegos, Carmen Solano-Agama, et al.
In Vivo (2023) Vol. 37, Iss. 3, pp. 1156-1163
Open Access | Times Cited: 3
Establishment and characterization of a recurrent malignant peripheral nerve sheath tumor cell line: RsNF
Xingnan Zhang, Chenhao Hu, Dezhi Li, et al.
Human Cell (2023) Vol. 37, Iss. 1, pp. 345-355
Open Access | Times Cited: 2
Alterations in serum metabolic profiles of early-stage hepatocellular carcinoma patients after radiofrequency ablation therapy
Fengmei Zhang, Jing Wu, Lei Zhang, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 243, pp. 116073-116073
Closed Access
Machine-learning prediction of a novel diagnostic model using mitochondria-related genes for patients with bladder cancer
Jian Li, Zhiyong Wang, Tianen Wang
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top